Markandeya Yogananda S, Tsubouchi Tadashi, Hacker Timothy A, Wolff Matthew R, Belardinelli Luiz, Balijepalli Ravi C
Cellular and Molecular Arrhythmia Research Program, Department of Medicine, University of Wisconsin, Madison, Wisconsin.
Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co. Ltd., Osaka, Japan.
Heart Rhythm. 2016 Nov;13(11):2228-2236. doi: 10.1016/j.hrthm.2016.08.007. Epub 2016 Aug 3.
Lamin A and C are nuclear filament proteins encoded by the LMNA gene. Mutations in the LMNA gene cause many congenital diseases known as laminopathies, including Emery-Dreifuss muscular dystrophy, Hutchinson-Gilford progeria syndrome, and familial dilated cardiomyopathy (DCM) with conduction disease. A missense mutation (N195K) in the A-type lamins results in familial DCM and sudden arrhythmic death.
The purpose of this study was to investigate the ion current mechanism of arrhythmia and DCM caused by the LaminA-N195K variant.
A homozygous mouse line expressing the Lmna-N195K mutation (Lmna) that exhibited arrhythmia, DCM, and sudden death was used. Using whole cell patch-clamp technique, we measured action potential duration (APD), Na currents (I) in ventricular myocytes isolated from Lmna, and wild-type mice.
Both peak and late I were significantly (P <.05) increased in Lmna ventricular myocytes. Similarly, Lmna ventricular myocytes exhibited significant (P <.005) prolongation of APD (time to 50% [APD] and 90% [APD] repolarization) and triggered activity. Acute application of ranolazine inhibited late I, shortened APD, and abolished triggered activity in Lmna ventricular myocytes.
Inhibition of late I may be an effective therapy in preventing arrhythmia in patients with LmnaN195K mutation-related DCM.
核纤层蛋白A和C是由LMNA基因编码的核丝状蛋白。LMNA基因突变会导致许多被称为核纤层蛋白病的先天性疾病,包括埃默里-德赖富斯肌营养不良症、哈钦森-吉尔福德早衰综合征以及伴有传导疾病的家族性扩张型心肌病(DCM)。A型核纤层蛋白中的一个错义突变(N195K)会导致家族性DCM和心律失常性猝死。
本研究旨在探讨由核纤层蛋白A-N195K变异引起的心律失常和DCM的离子电流机制。
使用表达Lmna-N195K突变(Lmna)的纯合小鼠品系,该品系表现出心律失常、DCM和猝死。采用全细胞膜片钳技术,我们测量了从Lmna和野生型小鼠分离的心室肌细胞的动作电位时程(APD)、钠电流(I)。
Lmna心室肌细胞的峰值I和晚期I均显著增加(P<.05)。同样,Lmna心室肌细胞的APD(复极化至50%[APD]和90%[APD]的时间)显著延长(P<.005)并出现触发活动。急性应用雷诺嗪可抑制Lmna心室肌细胞的晚期I,缩短APD并消除触发活动。
抑制晚期I可能是预防LmnaN195K突变相关DCM患者心律失常的有效治疗方法。